by Five Rivers Rx | Jan 7, 2021 | DEA
In November 2020, the Drug Enforcement Administration (DEA) issued a Notice of Proposed Rulemaking (NPRM) proposing to revise its regulations relating to suspicious orders of controlled substances. The proposed rules will clarify requirements to process a suspicious...
by Five Rivers Rx | Dec 17, 2020 | Industry News
Last month, Iowa became the second of five states to formally recognize/approve the NCDQS QAS Accreditation program, and the first state to approve the program by rule, revising Iowa Code section 17A.8(6). The Maryland Board of Pharmacy approved the NCDQS QAS...
by Five Rivers Rx | Nov 19, 2020 | NavigateSOM, Suspicious Order Monitoring
NavigateSOM is excited to announce the release of our User Manual. Our goal is to walk clients through step by step how to most effectively utilize every feature in their portal, giving them the most value. It begins with gaining access to your portal and some helpful...
by Five Rivers Rx | Nov 19, 2020 | Industry News
The headwinds for retail pharmacy continue to grow as new technology and services are poised to disrupt the dispensing of pharmaceuticals; and COVID-19 is accelerating the developments. Evolution of Pharmacy In just the past year, there have been various major...
by Five Rivers Rx | Nov 5, 2020 | Industry News, Puerto Rico
Five Rivers RX is making public comments on the Puerto Rico Department of Health’s proposed regulation Number 156B titled For the Operation of Establishments that Manufacture, Distribute, and Dispatch Medications in Puerto Rico. Five Rivers RX supports the aim of...
